Terrie Ramirez-Andersen is a seasoned professional in the field of clinical research and pharmacovigilance, currently serving as Senior Director and Early Development Team Lead at Genmab since May 2018. Prior roles include various directorial positions in clinical research and safety at Genmab, and Senior Pharmacovigilance Manager at Ferring Pharmaceuticals. Ramirez-Andersen's extensive experience also includes a tenure at Novo Nordisk in safety operations, as well as contributions as an Independent Scientific Expert for the European Commission's Innovative Medicines Initiative Joint Undertaking. Previous roles encompass leadership positions at LEO Pharma and Zealand Pharma, along with research responsibilities at H. Lundbeck A/S and as an Adjunct Professor at the University of Copenhagen. Educational qualifications include a Postdoctoral Fellowship in Cardiovascular Medicine from Stanford University School of Medicine and a PhD in Biomedical Sciences from UC San Diego School of Medicine.
This person is not in any teams
This person is not in any offices